Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coronary Artery Disease
|
1577 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||
Malignant Neoplasms
|
1641 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
80 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Carcinoma of lung
|
1204 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
cervical cancer
|
268 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Cervix carcinoma
|
283 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Colorectal Carcinoma
|
1962 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Hypertriglyceridemia
|
169 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Liver carcinoma
|
942 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Malignant neoplasm of lung
|
1142 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant neoplasm of prostate
|
1082 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant tumor of cervix
|
245 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Myocardial Infarction
|
680 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Obesity
|
1111 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Premature coronary artery atherosclerosis
|
43 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Primary malignant neoplasm of lung
|
981 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Prostate carcinoma
|
1168 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Renal Cell Carcinoma
|
288 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Tumor Progression
|
72 | 0.701 | 0.440 | 14 | 61747130 | 3 prime UTR variant | T/C | snv | 0.84 | 0.80 | 0.010 | 1.000 | 1 | 2016 | 2016 |